Peptide Synthesis Market Size To Reach USD 516.75 Million By 2028 Says Reports And Data

Reports and Data has recently published a research report on global Peptide Synthesis market forecast to 2028 providing an overview of the industry. The report offers precise information about market revenue growth, market size, market drivers, restraints, growth opportunities, and challenges along with details about segmentation and top companies. The global peptide synthesis market size is expected to reach USD 516.75 Million by 2028 and register a revenue CAGR of 6.4% over the forecast period, according to latest analysis by Reports and Data. Major factors driving market revenue growth are increasing use of peptides in pharmaceutical drugs, rise in research activities and availability of funding for R&D, and development of advanced technological peptide synthesizers.

Peptides are highly specific and effective signalling molecules that bind to specific cell surface receptors such as G protein-coupled receptors (GPCRs) or ion channels, causing intracellular effects. Peptides are an excellent starting point for the development of novel therapeutics due to their excellent pharmacological profile and intrinsic properties. In humans, their specificity has been shown to translate into high levels of protection, tolerability, and efficacy.

Peptide therapeutics have a lower processing complexity than protein-based biopharmaceuticals, resulting in lower manufacturing costs that are similar to those of small molecules. As peptides strike a balance between small molecules and biopharmaceuticals, the peptide synthesis market has seen a large rise in revenue.

Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/4007

In addition to conventional peptide design, a number of peptide technologies have emerged that indicate high potential growth opportunities in the peptide synthesis industry. Among them are multifunctional and cell penetrating peptides, peptide drug conjugates, and innovations focused on different routes of administration.

Peptides have a wide range of applications, ranging from medicine and biotechnology, to therapeutic peptide chemistry in the last decade. Use of peptide for commercial purposes is also on the rise, which is also propelling peptide synthesis market growth. Lupron, which is a peptide-based drug used to treat prostate cancer and other diseases, had global sales of more than USD 752 million in 2020. In addition, sales for Sanofi's Lantus reached USD 7 billion in 2017. Approximately 140 peptide drugs are in clinical trials and over 500 therapeutic peptides in preclinical processing, and are currently more than 80 FDA-approved peptide medicines are on the market.

Current peptide synthesis, on the other hand, is primarily focused on legacy technologies that use large amounts of highly volatile reagents and solvents. Lower performance, costly biocatalysts, and a lack of validation protocols are drawbacks of this technology, making peptide production by enzymatic methods difficult.

Some major players in the global peptide synthesis market include:

Genscript Biotech, Merck KGaA, Aapptec, Bachem Holdings, Anaspec, Biotage, CEM Corporation, Gyros Protein Technologies, Advanced Chemtech, and NEP (New England Peptide).

Some Key Highlights From the Report:

In 2020, reagents segment accounted for largest share among other product segments in the global peptide synthesis market.
The solid-phase synthesis segment is expected to register highest revenue CAGR during the forecast period.
In 2020, pharmaceutical & biotechnological companies segment accounted for largest revenue share owing to increasing number of R&D projects in genomics, molecular biology, and related fields.
North America accounted for largest revenue share in the global market in 2020. This can be attributed to major presence of key market players, increased availability of peptide synthesis technologies, as well as rising focus on producing peptide-based drugs on commercial scale.
The peptide synthesis market in Asia Pacific is expected to continue to register fastest revenue growth rate owing to increased investments by pharmaceutical and biotechnology companies as well as increasing R&D activities in countries in the region.

Request for Custom Research @ https://www.reportsanddata.com/request-customization-form/4007

Segments covered in the report:

For the purpose of this report, Reports and Data has segmented the global peptide synthesis market on the basis of product, technology, end use, and region:
Product Outlook (Revenue, USD Million; 2018 – 2028)

Reagents
Equipment
Peptide Synthesizers
Chromatography Equipment
Lyophilizers

Technology Outlook (Revenue, USD Million; 2018 – 2028)

Solid-phase Peptide Synthesis
Liquid-phase Peptide Synthesis
Hybrid & Recombinant Technology
End User Outlook (Revenue, USD Million; 2018 – 2028)

Pharmaceutical and Biotechnology Companies
Contract Development and Manufacturing Organizations
Academic and Research Institutes

Regional Outlook (Revenue, USD Million; 2018 – 2028)

North America
US
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Benelux
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of Asia Pacific
Latin America
Brazil
Rest of Latin America
Middle East and Africa
Saudi Arabia
UAE
South Africa
Rest of Middle East & Africa

Buy now your Exclusive copy of Report @ https://www.reportsanddata.com/checkout-form/4007

Explore Reports and Data's Prime Analysis of the global Pharma and Healthcare:

Gene Panel Market: https://www.reportsanddata.com/report-detail/gene-panel-market

Cell Viability Assays Market: https://www.reportsanddata.com/report-detail/cell-viability-assays-market

Contact Us, , John Watson, Head of Business Development, Address- 40 Wall St. 28th floor New York City, USA, Direct Line: +1-212-710-1370, E-mail: sales@reportsanddata.com

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

This release was published on openPR.